Details of Disease

General Information of Disease (ID: DISFBZLV)

Disease Name Dacryocystitis
Synonyms dacryoadenitis; Dacryocystitides; inflammation of lacrimal sac; Dacryoadenitides; lacrimal sac inflammation
Definition Inflammation of the lacrimal sac.
Disease Hierarchy
DIS184KT: Skin inflammation
DISWD40R: Disease
DIS5XTJD: Nasolacrimal duct disorder
DISFBZLV: Dacryocystitis
Disease Identifiers
MONDO ID
MONDO_0004926
MESH ID
D003607
UMLS CUI
C0010930
MedGen ID
3686
HPO ID
HP:0000620
SNOMED CT ID
85777005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 4 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Fusidic Acid DMWVCF3 Approved Small molecular drug [1]
Gentamicin DMKINJO Approved Small molecular drug [2]
Prednisolone DMQ8FR2 Approved Small molecular drug [3]
Tobramycin DMUI0CH Approved Small molecular drug [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 [Susceptibility of drug-resistant staphylococci isolated from different parts of the ocular anterior segment to common ophthalmic antibiotics]. Zhonghua Yan Ke Za Zhi. 2022 Aug 11;58(8):598-605.
2 Gentamicin FDA Label
3 Prednisolone FDA Label
4 Tobramycin FDA Label